Recent Posts
- HealthInvest Returns for 2026: Meet the Companies Shaping Australian Life Sciences
- Lifesaving Capital: How impact investing is shaping the future of biotech
- Investor Relations: the quiet advantage powering ASX microcaps
- HealthInvest Sydney: Life Sciences in the Investor Spotlight
- HealthInvest September 2025
Archives
ASEAN Dengue Day: Island Pharmaceuticals Investor briefing video
CEO and Managing Director at Island Pharmaceuticals Dr David Foster, Executive Chairman Dr Paul MacLeman, and Infectious Disease expert Prof Stephen Thomas MD discuss the most current understanding of the impact of dengue fever on the global community, the pace of growth in the ASEAN region and the changing battle against dengue in light of climate change and COVID-19.
CEO and Managing Director at Island Pharmaceuticals Dr David Foster, Executive Chairman Dr Paul MacLeman, and Infectious Disease expert Prof Stephen Thomas MD discuss the most current understanding of the impact of dengue fever on the global community, the pace of growth in the ASEAN region and the changing battle against dengue in light of climate change and COVID-19.
